Shark Tank's Namita Thappar-backed Emcure Pharma shares surge 20% in two sessions after robust Q4 earnings

Emcure Pharmaceuticals shares surged 10% to ₹1,288.65, driven by strong Q4FY25 results with a 64% profit increase. The company reported 20% revenue growth and plans to improve margins through new products. A final dividend of ₹3 per share was also announced.

Markets